Pharmosa Biopharm Total Current Liabilities

Pharmosa Biopharm (6875.TWO) currently reports a total current liabilities of $82M as of June 2026. That compares with $97M in the prior-year period — down 15.5% year over year. Use the charts on this page to explore Pharmosa Biopharm's total current liabilities history and peer comparisons.

Pharmosa Biopharm's total current liabilities decreased from $97M to $82M — a 15.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pharmosa Biopharm reported $82M in total current liabilities as of June 2026. That compares with $97M in the prior-year period — down 15.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $82M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pharmosa Biopharm, and consider following 6875.TWO for alerts when major investors trade the stock.

Pharmosa Biopharm is classified in the Healthcare sector. On total current liabilities, it currently shows $82M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6875.TWO with unrelated industries.